Skip to main
SYK

Stryker (SYK) Stock Forecast & Price Target

Stryker (SYK) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 27%
Buy 47%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

Stryker is well-positioned in the medical technology industry, with a diverse product portfolio and a strong global presence. The company's leadership position in operating room equipment, coupled with sustained revenue growth and strategic acquisitions, should provide a strong foundation for future growth. Additionally, Stryker's ability to recover from the cyber incident in 2026, as well as its continued focus on new product launches and cost efficiencies, make it a compelling investment opportunity.

Bears say

Stryker is a leading medical equipment company, but their recent cyber attack has had a significant negative impact on their first quarter results, leading to missed revenue and EPS expectations. They also face potential downside risks from a worsening market for elective procedures and hospital capital spending, and confounding inflationary pressures. However, there is potential upside for the company if they see strong growth in their key segments such as Hip, Neurovascular, Medical, and Endoscopy, as well as improvement in international markets and cost management. It is important to closely monitor their recovery from the cyber attack and market conditions in the coming quarters.

Stryker (SYK) has been analyzed by 15 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 47% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stryker (SYK) Forecast

Analysts have given Stryker (SYK) a Buy based on their latest research and market trends.

According to 15 analysts, Stryker (SYK) has a Buy consensus rating as of May 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $396.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $396.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stryker (SYK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.